The chemical substance known as 5-[3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl]-8(S)-hydroxy-1-methyl-1,4,5,6,7,8-hexahydropyrrolo[3,2-c]azepin-4-one, with the CAS number 191592-36-6, is a complex organic compound characterized by its multi-cyclic structure and the presence of various functional groups. It features a piperazine moiety, which is often associated with pharmacological activity, particularly in the realm of neuropharmacology. The fluorophenyl group contributes to its lipophilicity and potential interactions with biological targets. The hexahydropyrroloazepine framework suggests potential for binding to receptors or enzymes, making it of interest in medicinal chemistry. The presence of a hydroxyl group indicates potential for hydrogen bonding, which can influence solubility and reactivity. Overall, this compound may exhibit significant biological activity, warranting further investigation for therapeutic applications, particularly in the treatment of psychiatric or neurological disorders. Its structural complexity and specific substituents suggest a tailored approach in drug design and development.

5-[3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl]-8(S)-hydroxy-1-methyl-1,4,5,6,7,8-hexahydropyrrolo[3,2-c]azepin-4-one

191592-36-6: The chemical substance known as 5-[3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl]-8(S)-hydroxy-1-methyl-1,4,5,6,7,8-hexahydropyrrolo[3,2-c]azepin-4-one, with the CAS number 191592-36-6, is a complex organic compound characterized by its multi-cyclic structure and the presence of various functional groups. It features a piperazine moiety, which is often associated with pharmacological activity, particularly in the realm of neuropharmacology. The fluorophenyl group contributes to its lipophilicity and potential interactions with biological targets. The hexahydropyrroloazepine framework suggests potential for binding to receptors or enzymes, making it of interest in medicinal chemistry. The presence of a hydroxyl group indicates potential for hydrogen bonding, which can influence solubility and reactivity. Overall, this compound may exhibit significant biological activity, warranting further investigation for therapeutic applications, particularly in the treatment of psychiatric or neurological disorders. Its structural complexity and specific substituents suggest a tailored approach in drug design and development.

<p>"SUN-C5174 is a selective 5-HT2 antagonist with pA2=8.98; inhibits platelet aggregation and reduces thromboembolic death in mice at ≥0.3 mg/kg."</p>

CAS 191592-36-6

5-[3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl]-8(S)-hydroxy-1-methyl-1,4,5,6,7,8-hexahydropyrrolo[3,2-c]azepin-4-one

SUN-C5174

Ref: TM-T28884